指南与共识眼底病与葡萄膜炎小儿眼科与斜弱视

对存在视网膜母细胞瘤风险的儿童进行筛查:美国眼肿瘤学家和病理学家协会共识报告

Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists.
指南 / 共识 · Ophthalmology · 2017-10-18

该共识报告由美国眼肿瘤学家和病理学家协会(AAOOP)召集眼肿瘤学家、病理学家和遗传学家专家组制定,针对有视网膜母细胞瘤家族史的儿童提出筛查建议,强调基于遗传咨询和检测的风险分层,并按高、中、低风险调整检查频率和方式。

要点

  • 建议对所有高于群体风险的视网膜母细胞瘤风险儿童进行专门的眼科筛查。
  • 检查频率根据预期RB1突变风险调整,并通过遗传咨询和检测明确风险。
  • 检查计划按高、中、低风险儿童分层,高风险儿童需更频繁筛查,可优先选择麻醉下检查。

核心结论

  • 风险分层(包括遗传检测和咨询)是视网膜母细胞瘤风险升高儿童筛查的基础。

研究设计与样本

  • 共识专家组由美国眼肿瘤学家和病理学家协会(AAOOP)成员组成,并得到美国小儿眼科和斜视协会及美国儿科学会(AAP)支持。
  • 专家组包括来自不同地理区域视网膜母细胞瘤转诊中心的眼肿瘤学家、病理学家和遗传学家代表。
  • 风险人群定义为父母、兄弟姐妹或一级或二级亲属中有视网膜母细胞瘤家族史的人。

主要发现

  • 共识声明:建议对所有高于群体风险的视网膜母细胞瘤风险儿童进行专门的眼科筛查。
  • 检查频率根据预期RB1突变风险调整。
  • 遗传咨询和检测可明确有家族史儿童的视网膜母细胞瘤风险。
  • 检查计划根据高、中、低风险儿童进行分层。
  • 高风险视网膜母细胞瘤儿童需要更频繁的筛查,可优先选择麻醉下检查。

关键数值与推荐

  • 建议对所有高于群体风险的视网膜母细胞瘤风险儿童进行专门的眼科筛查。
  • 检查频率根据预期RB1突变风险调整。
  • 通过遗传咨询和检测明确有家族史儿童的视网膜母细胞瘤风险。
  • 检查计划按高、中、低风险儿童分层。
  • 高风险儿童需要更频繁的筛查,可优先选择麻醉下检查。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To provide a set of surveillance guidelines for children at risk for development of retinoblastoma. DESIGN: Consensus panel. PARTICIPANTS: Expert panel of ophthalmic oncologists, pathologists, and geneticists. METHODS: A group of members of the American Association of Ophthalmic Oncologists and Pathologists (AAOOP) with support of the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics (AAP) was convened. The panel included representative ophthalmic oncologists, pathologists, and geneticists from retinoblastoma referral centers located in various geographic regions who met and discussed screening approaches for retinoblastoma. A patient "at risk" was defined as a person with a family history of retinoblastoma in a parent, sibling, or first- or second-degree relative. MAIN OUTCOME MEASURES: Screening recommendations for children at risk for retinoblastoma. RESULTS: Consensus statement from the panel: (1) Dedicated ophthalmic screening is recommended for all children at risk for retinoblastoma above the population risk. (2) Frequency of examinations is adjusted on the basis of expected risk for RB1 mutation. (3) Genetic counseling and testing clarify the risk for retinoblastoma in children with a family history of the disease. (4) Examination schedules are stratified on the basis of high-, intermediate-, and low-risk children. (5) Children at high risk for retinoblastoma require more frequent screening, which may preferentially be examinations under anesthesia. CONCLUSIONS: Risk stratification including genetic testing and counseling serves as the basis for screening of children at elevated risk for development of retinoblastoma.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Skalet AH, Gombos DS, Gallie BL, et al. Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists. Ophthalmology. 2017. PMID: 29056300. doi:10.1016/j.ophtha.2017.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。